Rentokil
232 hedge funds and large institutions have $1.82B invested in Rentokil in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 119 increasing their positions, 44 reducing their positions, and 36 closing their positions.
170% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 44
36% more call options, than puts
Call options by funds: $21.1M | Put options by funds: $15.5M
14% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 36
6% more capital invested
Capital invested by funds: $1.71B → $1.82B (+$103M)
2% more funds holding
Funds holding: 228 → 232 (+4)
0.18% more ownership
Funds ownership: 2.25% → 2.43% (+0.18%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$28.9M |
| 2 |
MC
MIG Capital
Newport Beach,
California
|
+$24.7M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$24.2M |
| 4 |
TFM
Trian Fund Management
New York
|
+$13M |
| 5 |
Lazard Asset Management
New York
|
+$10.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$20.7M |
| 2 |
VC
Voss Capital
Houston,
Texas
|
-$12.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$11.2M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$7.59M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.99M |
RTO Hedge Fund Activity: Q2 2024 in Review
232 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q2 2024, worth a combined $1.82B — up 6% from $1.71B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new RTO positions and 36 closed out — a net gain of 5 holders — while 119 added to existing stakes and 44 trimmed.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $28.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $20.7M.
- 232 institutional investors held Rentokil (RTO) as of Q2 2024, up from 228 in Q1 2024.
- Funds reported $1.82B of Rentokil stock for Q2 2024, up 6% quarter-over-quarter.
- 41 funds opened new Rentokil positions in Q2 2024 and 36 closed out, a net change of +5 holders.
- The largest Rentokil buyer in Q2 2024 was Manulife (Manufacturers Life Insurance), an estimated $28.9M added.
- The largest Rentokil seller in Q2 2024 was T. Rowe Price Associates, an estimated $20.7M sold.
Based on aggregated 13F filings for Q2 2024.